Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus Type 1”

2,155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,155 results

Large-scale testing (Phase 3)Study completedNCT00234910
What this trial is testing

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Who this might be right for
HIV Infection
Abbott 152
Not applicableStudy completedNCT01771562
What this trial is testing

Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent

Who this might be right for
HIV-1
ANRS, Emerging Infectious Diseases 330
Post-approval studies (Phase 4)Study completedNCT01608269
What this trial is testing

Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy

Who this might be right for
HiV1- Positive
Therapeutic Concepts 30
Testing effectiveness (Phase 2)UnknownNCT06282783
What this trial is testing

Studying Topiramate for Re-Activating the HIV-1 Reservoir

Who this might be right for
HIV-1-infectionHivHIV Infections+1 more
Erasmus Medical Center 12
Not applicableStudy completedNCT00026676
What this trial is testing

Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine

Who this might be right for
HIV Infection
National Cancer Institute (NCI) 82
Post-approval studies (Phase 4)Study completedNCT01274780
What this trial is testing

Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients

Who this might be right for
HIV-1
Juan A. Arnaiz 180
Not applicableUnknownNCT05071378
What this trial is testing

Leveraging Family-Based Assets for Black MSM In House Ball Communities

Who this might be right for
HIV I Infection
State University of New York - Downstate Medical Center 168
Not applicableLooking for participantsNCT04160455
What this trial is testing

Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated.

Who this might be right for
AutophagyGalectinsHIV Infections+1 more
Centre Hospitalier Régional d'Orléans 180
Testing effectiveness (Phase 2)Study completedNCT00074997
What this trial is testing

An Efficacy and Safety Study of Autologous Cluster of Differentiation 34 (CD34+) Hematopoietic Progenitor Cells Transduced With Placebo or an Anti- Human Immunodeficiency Virus Type 1 (HIV-1) Ribozyme (OZ1) in Participants With HIV-1 Infection

Who this might be right for
HIV-1
Janssen-Cilag Pty Ltd 1
Testing effectiveness (Phase 2)WithdrawnNCT05130086
What this trial is testing

Islatravir (MK-8591) in Trans and Gender Diverse Participants (MK-8591-035)

Who this might be right for
Human Immunodeficiency Virus (HIV) Infections
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)Ended earlyNCT03493568
What this trial is testing

Switch From Dual Regimens Based on Dolutegravir Plus a Reverse Transcriptase Inhibitor to E/C/F/TAF in Virologically Suppressed, HIV-1 Infected Patients (Be-OnE)

Who this might be right for
HIV-1-infection
IRCCS San Raffaele 100
Large-scale testing (Phase 3)Study completedNCT01818596
What this trial is testing

Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment

Who this might be right for
HIVHIV Infections
Gilead Sciences 252
Testing effectiveness (Phase 2)Study completedNCT00398125
What this trial is testing

Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults

Who this might be right for
Infection, Human Immunodeficiency VirusHIV-1 Infection
GlaxoSmithKline 30
Not applicableLooking for participantsNCT07293559
What this trial is testing

Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States

Who this might be right for
HIV-1-infectionBreastfeedingPregnancy Related
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 1,150
Not applicableStudy completedNCT05294159
What this trial is testing

Implementing Long-Acting Novel Antiretrovirals

Who this might be right for
Human Immunodeficiency Viruses
Queen Mary University of London 114
Post-approval studies (Phase 4)Study completedNCT00466180
What this trial is testing

Adherence, Efficacy and Tolerance of Once-a-day Nevirapine-based Regimen in HIV-1 Infected Patients

Who this might be right for
HIV Infections
University Hospital, Caen 62
Post-approval studies (Phase 4)Study completedNCT01736761
What this trial is testing

A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.

Who this might be right for
HIV
St Stephens Aids Trust 36
Not applicableStudy completedNCT05044286
What this trial is testing

Longer-Acting PrEP in Transgender and Gender Diverse Texans

Who this might be right for
HIV-1-infection
University of Texas at Austin 565
Not applicableStudy completedNCT02926456
What this trial is testing

Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)

Who this might be right for
Human Immunodeficiency Virus
Janssen-Cilag S.p.A. 337
Testing effectiveness (Phase 2)Study completedNCT02738502
What this trial is testing

Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors

Who this might be right for
Maternal-fetal Infection Transmission
ANRS, Emerging Infectious Diseases 91
Load More Results